Evidence Supporting the Efficacy of Spinal Cord Stimulation (SCS)

High-level clinical evidence

Spinal cord stimulation was invented in the 1960s. It became FDA-approved in 1989. It was a promising therapy for many decades, but in 2016, there were major advances in the technology that have dramatically improved outcomes.

This therapy is effective for patients with back and neck pain that have failed traditional and conventional therapies including spine surgery. SCS also is effective for Complex Regional Pain Syndrome (CRPS) or Reflex Sympathetic Dystrophy (RSD). It helps treat nerve damage pain.

SCS involves a temporary trial first to test out if this treatment works before fully committing to a total implant.

Most clinical research studies report a 70% success rate. Check it out for yourself. I have provided a list of recently published peer-reviewed studies with links:

List of Research Studies

Burst Spinal Cord Stimulation: A Systematic Review and Pooled Analysis of Real-World Evidence and Outcomes Data

Dorsal root ganglion stimulation yielded higher treatment success rate for complex regional pain syndrome and causalgia at 3 and 12 months: a randomized comparative trial

Novel 10-kHz High-frequency Therapy (HF10 Therapy) Is Superior to Traditional Low-frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: The SENZA-RCT Randomized Controlled Trial

Spinal Cord Stimulation: Clinical Efficacy and Potential Mechanisms